Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1656-1661

  Mooiweer, Erik ^a   van der Meulen de Jong, Andrea E ^b   Ponsioen, Cyriel Y ^c   van der Woude, C Janneke ^d   van Bodegraven, Ad A ^e   Jansen, Jeroen M ^f   Mahmmod, Nofel ^g   Kremer, Willemijn ^a   Siersema, Peter D ^a   Oldenburg, Bas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^g ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Inflammatory Bowel Disease; Interval Colorectal Cancer; Surveillance

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DISEASE SURVEILLANCE; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; INTERVAL COLORECTAL CANCER; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ULCERATIVE COLITIS; COLORECTAL NEOPLASMS; COMPLICATION; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGICAL MONITORING; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MIDDLE AGED; NETHERLANDS; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR;

ADULT; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EPIDEMIOLOGICAL MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84939570268     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.04.183     Document Type: Article

References (21)

1. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990, 323:1228-1233.
2. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
3. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
4. Farraye F.A., Odze R.D., Eaden J., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138:738-745.
5. Lutgens M.W., Oldenburg B., Siersema P.D., et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer 2009, 101:1671-1675.
6. Karlen P., Kornfeld D., Brostrom O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998, 42:711-714.
7. Sanduleanu S., Rutter M.D. Interval colorectal cancers in inflammatory bowel disease: the grim statistics and true stories. Gastrointest Endosc Clin N Am 2014, 24:337-348.
8. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
9. le Clercq C.M., Bouwens M.W., Rondagh E.J., et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 2014, 63:957-963.
10. Verschuren E.C., Ong D.E., Kamm M.A., et al. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice. Intern Med J 2014, 44:40-49.
11. Velayos F.S., Liu L., Lewis J.D., et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology 2010, 139:1511-1518.
12. Eaden J.A., Ward B.A., Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000, 51:123-128.
13. van Rijn A.F., Fockens P., Siersema P.D., et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009, 15:226-230.
14. Lutgens M.W., van Oijen M.G., van der Heijden G.J., et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013, 19:789-799.
15. Beaugerie L., Svrcek M., Seksik P., et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013, 145:166-175.
16. Wang Y.R., Cangemi J.R., Loftus E.V., et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol 2013, 108:444-449.
17. Leung K., Pinsky P., Laiyemo A.O., et al. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc 2010, 71:111-117.
18. Kaminski M.F., Regula J., Kraszewska E., et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010, 362:1795-1803.
19. Ullman T.A., Itzkowitz S.H. Intestinal inflammation and cancer. Gastroenterology 2011, 140:1807-1816.
20. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
21. Annese V., Daperno M., Rutter M.D., et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013, 7:982-1018.